A5048182735- Tuberculosis Research and Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections
- Mobile Health and mHealth Applications
- HIV/AIDS drug development and treatment
- Mycobacterium research and diagnosis
- Pharmacovigilance and Adverse Drug Reactions
- Clinical practice guidelines implementation
- HIV, TB, and STIs Epidemiology
- Digital Mental Health Interventions
- Health Literacy and Information Accessibility
- Diagnosis and treatment of tuberculosis
- Phenothiazines and Benzothiazines Synthesis and Activities
- Healthcare Systems and Reforms
- Primary Care and Health Outcomes
- Lung Cancer Diagnosis and Treatment
- Global Health Care Issues
- Chronic Disease Management Strategies
- HIV, Drug Use, Sexual Risk
- ICT in Developing Communities
- Immunodeficiency and Autoimmune Disorders
- Immune responses and vaccinations
- Infectious Diseases and Tuberculosis
- Computational Drug Discovery Methods
- HIV/AIDS Impact and Responses
Ministry of Health
2017
World Health Organization - Pakistan
2011-2016
Objective To assess the problem of multidrug-resistant tuberculosis (MDR-TB) throughout Belarus and investigate associated risk factors.Methods In a nationwide survey in 2010-2011, 1420 (TB) patients were screened 934 new 410 previously treated cases TB found to meet inclusion criteria.Isolates Mycobacterium from each eligible patient tested for susceptibility anti-TB drugs.Sociobehavioural information was gathered interviews based on structured questionnaire.Findings MDR-TB 32.3% 75.6%...
Resistance to anti-tuberculosis (TB) medicines is a major public health threat in most countries of the former Soviet Union. As no representative and quality-assured information on magnitude this problem existed Belarus, survey was conducted capital city Minsk. Between November 2009 December 2010, 156 consecutively diagnosed new 68 previously treated culture-positive TB patients residing Minsk were enrolled survey. Mycobacterium tuberculosis isolates obtained from each patient tested for...
In 2014, the World Health Organization (WHO) developed End TB Strategy in response to a Assembly Resolution requesting Member States end worldwide epidemic of tuberculosis (TB) by 2035. For strategy's objectives be realised, next 20 years will need novel solutions address challenges posed health professionals, and affected people communities. Information communication technology presents opportunities for innovative approaches support efforts patient care, surveillance, programme management...
Abstract A recent innovation to help patients adhere daily tuberculosis (TB) treatment over many months is video (or virtually) observed therapy (VOT). VOT becoming increasingly feasible as mobile telephone applications and tablet computers become more widely available. Studies of the effectiveness in improving TB patient outcomes are being conducted.
Outcomes of treatment for multidrug-resistant tuberculosis (MDR-TB) remain poor worldwide. Among patients with MDR-TB in Belarus who started 2012, only 54% completed it successfully, failure reported 22% the patients; additionally, 11% died and 13% were lost to follow-up or remained unevaluated. In Belarus, improve outcomes, bedaquiline was introduced June 2015. The national TB program developed measures monitor safety effectiveness bedaquiline-containing regimens line World Health...
Settings: Tuberculosis (TB) health facilities in the Gomel Region, Republic of Belarus-settings with a high burden multidrug-resistant TB (MDR-TB) and human immunodeficiency virus (HIV) infection.Objective: To determine treatment outcomes among MDR-TB patients diagnosed 2009-2010 factors associated unsuccessful (death, failure loss to follow-up).Design: Retrospective cohort study involving review an electronic patient database maintained under National Control Programme.Results: Of 517...
Belarus (Eastern Europe) is facing an epidemic of multidrug-resistant tuberculosis (MDR-TB). In 2012, rapid molecular diagnostics were prioritised for sputum smear-positive pulmonary (PTB) patients to diagnose MDR-TB, while smear-negative TB (SN-PTB) investigated using conventional methods, often delaying the diagnosis MDR-TB by 2-4 months.To determine proportion among SN-PTB registered in 2012 and associated clinical demographic factors.Retrospective cohort study countrywide data from...
TB incidence and mortality in Belarus has been progressively falling from 54 to 41 12.1 6.8 per 100000, accordingly, for the last 7 years. Nevertheless, number of HIV/TB co-infected rises dramatically. According a recent nationwide drug resistance survey, MDR-TB was found 32.3% new 75.6% previously treated cases. Results treatment are far satisfactory (51% success, 11% deaths). Risk factors acquisition unfavorable outcome following: young age, alcohol abuse, HIV, history imprisonment,...
In Belarus and several EECA countries, periodic population-based chest X-ray “fluorography programme” use as a mass screening tool for the diagnosis of tuberculosis (TB) has been used decades. This also often justified early detection lung cancer (LC), although no mortality benefits were demonstrated by with in international randomized trials. Belarus, fluorography testing is mandatory every one to three years all adults depending on age so-called “risk groups”. The World Bank WHO estimate...